Amundi Trims Holdings in Astera Labs, Inc. $ALAB

Key Points

• Amundi cut its Astera Labs position by 15.4% in the second quarter, selling 288,942 shares and retaining 1.59 million shares worth approximately $768.9 million. Institutional investors collectively own 60.47% of the company.
• Astera Labs reported stronger-than-expected quarterly results, with EPS of $0.80 versus the $0.69 consensus and revenue of $392.4 million, up 104.5% year over year. Management guided for third-quarter EPS of $1.16 to $1.21.
• The stock remains volatile and highly valued, trading near $310 with a P/E ratio of 153.66 and beta of 3.77. While analysts maintain a “Moderate Buy” consensus and a $348.33 average price target, insiders have sold roughly $209.7 million in shares over the past 90 days.

Amundi decreased its position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 15.4% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,591,888 shares of the company's stock after selling 288,942 shares during the quarter. Amundi owned 0.92% of Astera Labs worth $768,914,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the company. Greenleaf Trust lifted its stake in Astera Labs by 1.8% during the 2nd quarter. Greenleaf Trust now owns 2,000 shares of the company's stock valued at $966,000 after acquiring an additional 36 shares during the period. Glenmede Trust Co. NA raised its stake in shares of Astera Labs by 2.7% during the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company's stock valued at $209,000 after buying an additional 51 shares during the last quarter. Keating Financial Advisory Services Inc. purchased a new position in shares of Astera Labs during the 2nd quarter valued at about $25,000. Lido Advisors LLC lifted its holdings in shares of Astera Labs by 0.5% in the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company's stock valued at $2,046,000 after buying an additional 57 shares during the period. Finally, Archer Investment Corp acquired a new position in shares of Astera Labs in the 2nd quarter valued at about $30,000. Hedge funds and other institutional investors own 60.47% of the company's stock.

Insider Buying and Selling

In other Astera Labs news, CEO Jitendra Mohan sold 90,630 shares of the stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the transaction, the chief executive officer directly owned 1,266,665 shares of the company's stock, valued at $431,109,432.75. This trade represents a 6.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the completion of the sale, the director owned 253,863 shares in the company, valued at approximately $71,114,642.19. This trade represents a 41.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 592,244 shares of company stock worth $209,729,973 in the last 90 days. 10.40% of the stock is owned by insiders.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Demand for Astera Labs’ Scorpio, Aries and Taurus connectivity platforms is supporting expectations for strong third-quarter growth and strengthening the company’s position in AI data-center infrastructure. ALAB Stock Down 24% in a Month: Should Investors Buy the Dip or Wait?
• Positive Sentiment: The company’s latest quarterly results exceeded expectations, with earnings per share of $0.80 versus the $0.69 consensus estimate and revenue of $392.4 million versus $360.85 million. Revenue rose 104.5% year over year, while management issued third-quarter EPS guidance of $1.16 to $1.21.
• Positive Sentiment: Analyst sentiment remains generally constructive: Astera Labs has a “Moderate Buy” consensus rating and an average price target of $348.33, above recent trading levels. Northland upgraded the shares to outperform with a $350 target, while Morgan Stanley maintained an overweight rating with a $335 target.
• Neutral Sentiment: Despite the favorable growth outlook, ALAB has declined 13.9% since its latest earnings report and 24% over the past month, reflecting elevated valuation expectations and uncertainty about the pace of future growth. The stock’s high beta and elevated earnings multiple may contribute to volatility. Why Is Astera Labs Down Since Its Earnings Report?
• Negative Sentiment: Director Manuel Alba sold 183,000 shares for approximately $51.3 million, reducing his holdings by 41.9%. Director Stefan Dyckerhoff separately sold 12,499 shares worth about $3.4 million. The transactions were made under pre-arranged Rule 10b5-1 plans, which reduces their value as a discretionary bearish signal, but the sales may still weigh on investor sentiment and add near-term supply. SEC Insider Trading Filing

Astera Labs Price Performance

NASDAQ:ALAB opened at $310.40 on Monday. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48. The stock has a market capitalization of $53.85 billion, a PE ratio of 153.66 and a beta of 3.77. The stock's 50-day moving average price is $330.74 and its 200-day moving average price is $255.24.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts' consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company had revenue of $392.40 million during the quarter, compared to analysts' expectations of $360.85 million. During the same quarter in the prior year, the firm posted $0.44 EPS. Astera Labs's quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Sell-side analysts expect that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts recently commented on ALAB shares. Royal Bank Of Canada raised their target price on Astera Labs from $425.00 to $500.00 and gave the stock an "outperform" rating in a report on Wednesday, August 5th. Susquehanna boosted their price target on Astera Labs from $230.00 to $275.00 and gave the company a "neutral" rating in a report on Friday, July 31st. Barclays upped their price objective on Astera Labs from $200.00 to $325.00 and gave the stock an "equal weight" rating in a research report on Monday, July 20th. Bank of America raised their price objective on shares of Astera Labs from $240.00 to $450.00 and gave the stock a "neutral" rating in a research note on Tuesday, June 23rd. Finally, Zacks Research raised shares of Astera Labs from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $348.33.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source